News | FFR Technologies | July 26, 2018

Updated SCAI Expert Consensus Says Either FFR, iFR Can Be Used

iFR reference numbers posted for new users in the cath lab at Northwestern Medicine's Central DuPage Hospital in Winfield, Ill.

July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert consensus statement in July for the use of invasive coronary physiological assessments. It recommends either fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) technologies can be used to assess the hemodynamic significance of coronary lesions to determine if a stent is needed. The statement said physiologicaly guided percutaneous coronary intervention (PCI) results in better clinical outcomes and saves resources compared to angiographic image guidance alone.[1] 

Both iFR and FFR are deemed “definitely beneficial” for assessing the functional significance of intermediate coronary stenoses when noninvasive stress imaging is not available or does not provide a definitive answer. SCAI sees probable benefits when FFR or iFR are used to reclassify the number of vessels that are diseased in patients with multivessel disease.

SCAI’s updated consensus statement was published in the SCAI journal Catherization and Cardiovascular Interventions. Based on the data from the DEFINE-FLAIR and iFR Swedeheart trials showing that the technique is noninferior to FFR for guiding decisions about intervening on intermediate lesions in patients with stable angina or non-STEMI acute coronary syndrome (ACS).[2,3]

The authors also spend some time covering the utility of iFR and/or FFR in stable ischemic heart disease, multivessel coronary artery disease (CAD), left main coronary stenosis, ACS, STEMI, aortic stenosis, tandem and serial lesions, and bypass grafts.

Access the expert consensus statement article. 

 

Related FFR and iFR Content:

What is New in FFR Technology

VIDEO: iFR Equal to FFR Outcomes in Coronary Lesion Evaluation

ORBITA: FFR and iFR as Predictors Placebo-controlled Response to PCI

VIDEO: iFR Found More Cost Effective Over Standard FFR

 

References: 

1. Amir Lotfi, Justin E. Davies, William F. Fearon, et al. Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions, First published: 03 July 2018 https://doi.org/10.1002/ccd.27672

2. Justin E. Davies, Sayan Sen, Hakim-Moulay Dehbi, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI, N Engl J Med 2017; 376:1824-1834. DOI: 10.1056/NEJMoa1700445

3. Matthias Götberg, Evald H. Christiansen, Ingibjörg J. Gudmundsdottir, et al.  Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med 2017; 376:1813-1823. DOI: 10.1056/NEJMoa1616540
 

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init